Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,124 | 504 | 99.7% |
| Education | $31.99 | 31 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,576 | 73 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,268 | 66 | $0 (2024) |
| Novo Nordisk Inc | $860.96 | 45 | $0 (2024) |
| PFIZER INC. | $818.03 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $643.27 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $624.62 | 36 | $0 (2024) |
| ABBVIE INC. | $456.60 | 23 | $0 (2024) |
| Gilead Sciences, Inc. | $381.90 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $285.45 | 17 | $0 (2021) |
| Lilly USA, LLC | $284.10 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,135 | 50 | PFIZER INC. ($240.65) |
| 2023 | $1,161 | 55 | PFIZER INC. ($273.43) |
| 2022 | $1,151 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($249.05) |
| 2021 | $1,637 | 104 | Boehringer Ingelheim Pharmaceuticals, Inc. ($290.10) |
| 2020 | $1,291 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($258.55) |
| 2019 | $740.53 | 37 | UCB, Inc. ($124.99) |
| 2018 | $1,290 | 77 | Boehringer Ingelheim Pharmaceuticals, Inc. ($231.07) |
| 2017 | $1,750 | 95 | Boehringer Ingelheim Pharmaceuticals, Inc. ($367.13) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.58 | General |
| 12/17/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: VACCINE | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: PAIN | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.50 | General |
| 07/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: PAIN | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $130.31 | General |
| Category: HBV | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,073 | 1,532 | $191,175 | $114,428 |
| 2022 | 16 | 1,067 | 1,426 | $177,403 | $110,685 |
| 2021 | 14 | 946 | 1,336 | $151,742 | $93,504 |
| 2020 | 16 | 948 | 1,265 | $135,818 | $70,836 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 301 | 690 | $86,250 | $50,358 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $30,820 | $20,972 | 68.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 124 | $21,700 | $12,228 | 56.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 42 | $9,660 | $6,317 | 65.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 29 | 29 | $7,830 | $5,737 | 73.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 59 | 59 | $4,990 | $4,244 | 85.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $5,075 | $4,239 | 83.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,130 | $2,380 | 76.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $2,440 | $2,266 | 92.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 183 | 200 | $11,000 | $2,209 | 20.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 26 | $2,080 | $1,186 | 57.0% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 43 | 51 | $3,570 | $855.47 | 24.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $680.00 | $631.38 | 92.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $990.00 | $557.00 | 56.3% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 13 | 14 | $490.00 | $118.08 | 24.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 18 | 26 | $260.00 | $83.46 | 32.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 21 | $210.00 | $46.20 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 263 | 551 | $68,875 | $40,647 | 59.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 143 | 143 | $31,740 | $22,386 | 70.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 140 | $24,500 | $15,013 | 61.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 49 | $11,270 | $8,146 | 72.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 79 | 79 | $6,320 | $5,415 | 85.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $4,595 | $3,768 | 82.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $3,525 | $3,316 | 94.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 82 | 82 | $3,280 | $3,005 | 91.6% |
About Dr. Tommy Kuo, MD
Dr. Tommy Kuo, MD is a Family Medicine healthcare provider based in San Mateo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851396469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tommy Kuo, MD has received a total of $10,156 in payments from pharmaceutical and medical device companies, with $1,135 received in 2024. These payments were reported across 535 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,124).
As a Medicare-enrolled provider, Kuo has provided services to 4,034 Medicare beneficiaries, totaling 5,559 services with total Medicare billing of $389,452. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location San Mateo, CA
- Active Since 06/20/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851396469
Products in Payments
- JARDIANCE (Drug) $885.91
- FARXIGA (Drug) $615.71
- NURTEC ODT (Drug) $541.45
- STIOLTO RESPIMAT (Drug) $536.48
- TRELEGY ELLIPTA (Drug) $410.72
- JANUVIA (Drug) $395.34
- Ozempic (Drug) $324.36
- Trintellix (Drug) $232.41
- UBRELVY (Drug) $216.52
- XARELTO (Drug) $210.24
- BEVESPI AEROSPHERE (Drug) $190.25
- ELIQUIS (Drug) $188.03
- QUVIVIQ (Drug) $179.84
- NUEDEXTA (Drug) $158.53
- Rybelsus (Drug) $153.95
- Vemlidy (Drug) $130.31
- BREZTRI (Drug) $129.52
- PREVNAR 13 (Biological) $124.36
- Mitigare (Drug) $123.68
- GRALISE (Drug) $123.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Mateo
Dr. Kristen Willison, Md, MD
Family Medicine — Payments: $4,829
Dr. Alexander Moldanado, M.d, M.D
Family Medicine — Payments: $3,946
Carolina Vogel, Do, DO
Family Medicine — Payments: $676.19
Mr. Richard Young, Md, MD
Family Medicine — Payments: $647.16
Dr. Mandeep Bajwa, M.d, M.D
Family Medicine — Payments: $506.24
Dr. Masayasu Kihira, Md Phd, MD PHD
Family Medicine — Payments: $500.32